Literature DB >> 4025661

Premarital rubella vaccination program.

R L Vogt, S W Clark.   

Abstract

A two-year Vermont program identified 494 (7 per cent) of 6,982 premarital female serologies that were seronegative (less than 1:8) to rubella by hemagglutination inhibition (HI) titer. All 494 susceptible patients and their physicians were notified of their results by letter. The State Health Department received reports that a total of 194 (39 per cent) of the susceptible patients had received rubella vaccinations as a result of their notifications. Intensive follow-up of susceptibles appears to be important factor in the success of premarital rubella screening programs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025661      PMCID: PMC1646332          DOI: 10.2105/ajph.75.9.1088

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  A cost-benefit analysis of a mandatory premarital rubella-antibody screening program.

Authors:  M E Farber; S N Finkelstein
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

2.  Mandatory premarital rubella serologic testing in Colorado. A preliminary report.

Authors:  F N Judson; B S Shaw; T M Vernon
Journal:  JAMA       Date:  1974-08-26       Impact factor: 56.272

3.  Congenital rubella. Pathogenesis and immunology.

Authors:  J A Dudgeon
Journal:  Am J Dis Child       Date:  1969-07

4.  Benefit-cost analysis of rubella vaccination policy.

Authors:  S C Schoenbaum; L Hyde JN Jr Bartoshesky; K Crampton
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

5.  Premarital rubella screening in Rhode Island.

Authors:  E Lieberman; G A Faich; P R Simon; R J Mullan
Journal:  JAMA       Date:  1981-04-03       Impact factor: 56.272

  5 in total
  2 in total

1.  New Mexico's premarital rubella test program.

Authors:  C M Sewell; H F Hull; J Montes; A Ortiz
Journal:  Am J Public Health       Date:  1986-10       Impact factor: 9.308

Review 2.  Preconception care: preventing and treating infections.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.